HEADLINES
FEATURED
Head-to-head trial finds pilocarpine 0.4% resulted in no significant changes in ciliary muscle or lens thickness following dosing.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
